相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Variant of SLC1A5 Is a Mitochondrial Glutamine Transporter for Metabolic Reprogramming in Cancer Cells
Hee Chan Yoo et al.
CELL METABOLISM (2020)
The HGF-MET axis coordinates liver cancer metabolism and autophagy for chemotherapeutic resistance
Xing Huang et al.
AUTOPHAGY (2019)
Targeting glutamine-addiction and overcoming CDK4/6 inhibitor resistance in human esophageal squamous cell carcinoma
Shuo Qie et al.
NATURE COMMUNICATIONS (2019)
LKB1 and KEAP1/NRF2 Pathways Cooperatively Promote Metabolic Reprogramming with Enhanced Glutamine Dependence in KRAS-Mutant Lung Adenocarcinoma
Ana Galan-Cobo et al.
CANCER RESEARCH (2019)
In vivo imaging of mitochondrial membrane potential in non-small-cell lung cancer
Milica Momcilovic et al.
NATURE (2019)
Sirtuin 4 Depletion Promotes Hepatocellular Carcinoma Tumorigenesis Through Regulating Adenosine-Monophosphate-Activated Protein Kinase Alpha/Mammalian Target of Rapamycin Axis in Mice
Yun-Shan Wang et al.
HEPATOLOGY (2019)
Targeting glutaminase 1 attenuates sternness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt/beta-catenin pathway
Binghua Li et al.
EBIOMEDICINE (2019)
Targeting glutaminolysis in chondrosarcoma in context of the IDH1/2 mutation
Elisabeth F. P. Peterse et al.
BRITISH JOURNAL OF CANCER (2018)
The GSK3 Signaling Axis Regulates Adaptive Glutamine Metabolism in Lung Squamous Cell Carcinoma
Milica Momcilovic et al.
CANCER CELL (2018)
Recent Development of Small Molecule Glutaminase Inhibitors
Minsoo Song et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2018)
Metabolic vulnerability of cisplatin-resistant cancers
Florine Obrist et al.
EMBO JOURNAL (2018)
Glutathione metabolism in cancer progression and treatment resistance
Ankita Bansal et al.
JOURNAL OF CELL BIOLOGY (2018)
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
Masatoshi Kudo et al.
LANCET (2018)
Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models
Michael L. Schulte et al.
NATURE MEDICINE (2018)
Disruption of Amino Acid Homeostasis by Novel ASCT2 Inhibitors Involves Multiple Targets
Angelika Broer et al.
FRONTIERS IN PHARMACOLOGY (2018)
Glutamine addiction activates polyglutamine-based nanocarriers delivering therapeutic siRNAs to orthotopic lung tumor mediated by glutamine transporter SLC1A5
Cuifeng Wang et al.
BIOMATERIALS (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
A tale of two glutaminases: homologous enzymes with distinct roles in tumorigenesis
William P. Katt et al.
FUTURE MEDICINAL CHEMISTRY (2017)
Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1
Haojie Jin et al.
GASTROENTEROLOGY (2017)
Glutaminase and poly(ADP-ribose) polymerase inhibitors suppress pyrimidine synthesis and VHL-deficient renal cancers
Arimichi Okazaki et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Metabolic Imaging of Glutamine in Cancer
Lin Zhu et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Metabolic recycling of ammonia via glutamate dehydrogenase supports breast cancer biomass
Jessica B. Spinelli et al.
SCIENCE (2017)
Adaptive Reprogramming of De Novo Pyrimidine Synthesis Is a Metabolic Vulnerability in Triple-Negative Breast Cancer
Kristin K. Brown et al.
CANCER DISCOVERY (2017)
Amino acid homeostasis and signalling in mammalian cells and organisms
Stefan Broer et al.
BIOCHEMICAL JOURNAL (2017)
[18F](2S,4R)4-Fluoroglutamine PET Detects Glutamine Pool Size Changes in Triple-Negative Breast Cancer in Response to Glutaminase Inhibition
Rong Zhou et al.
CANCER RESEARCH (2017)
Understanding the Intersections between Metabolism and Cancer Biology
Matthew G. Vander Heiden et al.
CELL (2017)
From Krebs to clinic: glutamine metabolism to cancer therapy
Brian J. Altman et al.
NATURE REVIEWS CANCER (2016)
Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition
Nathalie Jacque et al.
BLOOD (2015)
Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis
Yan Xiang et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Determination of Phosphate-activated Glutaminase Activity and Its Kinetics in Mouse Tissues using Metabolic Mapping (Quantitative Enzyme Histochemistry)
Dennis Botman et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2014)
Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer
Matt I. Gross et al.
MOLECULAR CANCER THERAPEUTICS (2014)
A phase I dose-escalation trial of 2-deoxy-D-glucose alone or combined with docetaxel in patients with advanced solid tumors
Luis E. Raez et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway
Jaekyoung Son et al.
NATURE (2013)
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Patrick S. Ward et al.
CANCER CELL (2012)
Prognostic PET 18F-FDG Uptake Imaging Features Are Associated with Major Oncogenomic Alterations in Patients with Resected Non-Small Cell Lung Cancer
Viswam S. Nair et al.
CANCER RESEARCH (2012)
Preparation and Characterization of L-[5-C-11]-Glutamine for Metabolic Imaging of Tumors
Wenchao Qu et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development
G Kelloff et al.
CLINICAL CANCER RESEARCH (2005)
Interorgan ammonia metabolism in liver failure
SWMO Damink et al.
NEUROCHEMISTRY INTERNATIONAL (2002)
分享论文
